Old Web
English
Sign In
Acemap
>
authorDetail
>
L. Jin
L. Jin
Eli Lilly and Company
Medicine
Internal medicine
Physical therapy
Oncology
Osteoporosis
3
Papers
119
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Teriparatide for osteoporosis: importance of the full course.
2016
Osteoporosis International
Robert Lindsay
John H. Krege
Fernando Marin
L. Jin
Jan J. Stepan
Show All
Source
Cite
Save
Citations (80)
Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database
2016
Osteoporosis International
D.C. Chan
C. H.-C. Chang
L.-C. Lim
A. J. M. Brnabic
Jau-Yih Tsauo
Russel Burge
F.-Y. Hsiao
L. Jin
Sirel Gurbuz
Rong-Sen Yang
Show All
Source
Cite
Save
Citations (20)
OP0021 A phase 2 study of multiple subcutaneous doses of LY2439821, an anti-IL-17 monoclonal antibody, in patients with rheumatoid arthritis in two populations: Naïve to biologic therapy or inadequate responders to tumor necrosis factor alpha inhibitors
2013
Annals of the Rheumatic Diseases
Mark C. Genovese
Maria Greenwald
Chul-Soo Cho
Alberto Berman
L. Jin
Gregory S. Cameron
L. Wang
Li Xie
Daniel K. Braun
Pierre-Yves Berclaz
Subhashis Banerjee
Show All
Source
Cite
Save
Citations (19)
1